Source: BioBridges Blog

BioBridges Blog MedTech 2025: Prepare for What’s Next

MedTech companies have had challenges obtaining investor funding and have been operating with lean teams this past year. Will this continue into 2025, or will there be a resurgence of capital? We talked to leading industry experts to get their take on what’s next for MedTech.  Listen to the full webinar Here are some highlights...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more